MicroRNAs in microglia: deciphering their role in neurodegenerative diseases

Shweta Pradip Jadhav1

  • 1Thermo Fisher Scientific, Waltham, MA, United States.

Insights

MicroRNAs (miRNAs) critically regulate microglia, the brain's immune cells. Their dysregulation in neurodegenerative diseases drives disease progression by altering microglial function and phenotype.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Microglia are key immune cells in the central nervous system (CNS), essential for neural homeostasis and response to injury.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are increasingly recognized for their role in cellular functions.
  • Dysregulation of microglial function is implicated in the pathogenesis of various neurodegenerative diseases.

Purpose of the Study:

  • To provide a comprehensive review of the role of microRNAs in microglia.
  • To elucidate the implications of miRNA dysregulation in microglia for neurodegenerative disease pathogenesis.
  • To synthesize current knowledge on miRNA-mediated regulation of microglial activation, cytokine production, and phagocytosis.

Main Methods:

  • Literature review synthesizing current research findings.
  • Analysis of studies investigating miRNA expression and function in microglia.
  • Exploration of specific miRNAs (e.g., miR-155) and their impact on microglial responses.

Main Results:

  • MicroRNAs significantly influence microglial activation, cytokine release, and phagocytic capabilities.
  • Dysregulated miRNA expression in microglia contributes to neuroinflammation and neurodegeneration in diseases like Alzheimer's, Parkinson's, ALS, and MS.
  • Specific miRNAs modulate microglial phenotype, potentially shifting them from a protective to a detrimental state.

Conclusions:

  • MicroRNAs are critical regulators of microglial function with profound implications in neurodegenerative diseases.
  • Targeting specific miRNAs offers potential therapeutic strategies for neurodegenerative conditions.
  • Understanding miRNA-microglia interactions is crucial for developing novel treatments for CNS disorders.